Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | TLR2 | O60603 | 1/20 | 0.32 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | DGKA | P23743 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26418533 | 1.00 | STING1 (0.34) | STING1ALDH1A1HDAC3HDAC1HDAC2 | |
| SCHEMBL12660493 | 1.00 | STING1 (0.34) | STING1ALDH1A1HDAC3HDAC1HDAC2 | |
| SCHEMBL25695697 | 1.00 | STING1 (0.34) | STING1ALDH1A1HDAC3HDAC1HDAC2 | |
| SCHEMBL15697678 | 1.00 | STING1 (0.34) | STING1ALDH1A1HDAC3HDAC1HDAC2 | |
| SCHEMBL12906508 | 1.00 | STING1 (0.34) | STING1ALDH1A1HDAC3HDAC1HDAC2 | |
| SCHEMBL13573633 | 1.00 | STING1 (0.34) | STING1ALDH1A1HDAC3HDAC1HDAC2 | |
| SCHEMBL19532910 | 1.00 | STING1 (0.34) | STING1ALDH1A1HDAC3HDAC1HDAC2 | |
| SCHEMBL19532911 | 1.00 | STING1 (0.34) | STING1ALDH1A1HDAC3HDAC1HDAC2 | |
| SCHEMBL12092172 | 0.98 | STING1 (0.35) | STING1ALDH1A1HDAC3HDAC1HDAC2 | |
| SCHEMBL18843243 | 0.92 | STING1 (0.37) | STING1HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067640-A1 | PHENYL MALEIMIDE LINKER AGENTS | FIREFLY BIO, INC. | 2024-02-29 | — | — | US | disclosed |
| US-20230131121-A1 | BRANCHED DISCRETE PEG CONSTRUCTS | AUDAX PRIVATE DEBT LLC, AS AGENT | 2023-04-27 | — | — | US | disclosed |
| US-20170313656-A1 | Branched Discrete PEG Constructs | QUANTA BIODESIGN, LTD. | 2017-11-02 | — | — | US | disclosed |
| WO-2015038579-A1 | DISCRETE PEG BASED DYES | EQUIP, LLC (US) | 2015-03-19 | — | — | WO | disclosed |
| US-20130052130-A1 | Branched Discreet PEG Constructs | UNIVERSITY OF WASHINGTON (US) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170313656-A1 | Branched Discrete PEG Constructs | BTD, IDUA, DNPEP | STING1 2568/4885ALDH1A1 939/4885HDAC3 1380/4885 |
| US-20230131121-A1 | BRANCHED DISCRETE PEG CONSTRUCTS | BTD, IDUA, DNPEP | STING1 2634/4885ALDH1A1 888/4885HDAC3 1351/4885 |
| US-20240067640-A1 | PHENYL MALEIMIDE LINKER AGENTS | TPX2, H1-4, MAPT | STING1 4055/4885ALDH1A1 4502/4885HDAC3 161/4885 |
| US-20130052130-A1 | Branched Discreet PEG Constructs | BTD, DNPEP, IDUA | STING1 2870/4885ALDH1A1 1014/4885HDAC3 912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.